Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.010
-0.030 (-1.47%)
Jan 22, 2025, 4:00 PM EST - Market closed
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $252.38 million as of January 22, 2025. Its market cap has decreased by -31.54% in one year.
Market Cap
252.38M
Enterprise Value
153.39M
1-Year Change
-31.54%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $252.38M, an increase of 115.65%. That is a compound annual growth rate of 22.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 242.34M | 14.88% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |